Cardiometabolic Disorders News

Childhood amblyopia, or “lazy eye,” was associated with increased likelihood of cardiometabolic risk factors in adulthood and a potential for increased risk for heart attack and death, researchers reported.

GLP-1 receptor agonists come with known adverse events — some common and some rare — but recent reports by the public of alopecia and suicidal ideation have the FDA investigating.

People living in extreme poverty had a higher prevalence of heart disease risk factors such as hypertension, diabetes, smoking, obesity and dyslipidemia than previously thought, according to an analysis of people from 78 countries.

Adults with obesity who underwent bariatric surgery had improvements in multiple cardiometabolic measures after surgery, according to findings published in the Journal of the Endocrine Society.

Middle-aged adults who eat more plant-based foods and fewer animal-based products are less likely to develop incident diabetes, according to study findings published in Diabetes Care.

Regeneron Pharmaceuticals announced the FDA extended its approval of alirocumab as an adjunct to diet and other LDL-lowering therapies to include patients aged 8 years and older with heterozygous familial hypercholesterolemia.

Bariatric surgery will continue to be a therapeutic option for obesity and early diabetes in the future and may be used in combination with newer medications, according to a speaker.

Individuals with elevated and worsening metabolic syndrome had an increased risk for developing an array of cancer types compared with those who did not, according to results published in Cancer.

Novo Nordisk and the FDA announced approval of a new indication for semaglutide 2.4 mg for reduction of risk for major adverse cardiovascular events in adults with overweight or obesity and established CVD.

Adults with a higher BMI and waist-to-hip ratio may be more likely to report worse depression, according to study findings published in PLOS ONE.